MorphoSys has acquired all outstanding shares of the Dutch biopharmaceutical company Lanthio Pharma B.V. Read the full story
Tag Archive | "MorphoSys"
Morphosys acquires lanthipeptide technology from Lanthio Pharma
Posted on 16 October 2014
MorphoSys and Lanthio Pharma acquires of Lanthio Pharma's lanthipeptide technology, which will be used for drug discovery by MorphoSys. Read the full story
Partnering Agreements with Morphosys
Posted on 15 October 2014
The Partnering Agreements with Morphosys report provides an in-depth insight into the partnering interests and activities of one of the worlds leading biopharma companies. Read the full story
MorphoSys: Partnering activity 2009-2014
Posted on 22 September 2014
MorphoSys, a leader in antibody drug discovery, has emerged as a top 50 big biotech company with its product pipeline and partnering strategy. Read the full story
MorphoSys M&A deals 2009-2014
Posted on 12 September 2014
MorphoSys has announced only one acquisition in the past 5 years. Read the full story
Morphosys: Clear leaders in antibody generation
Posted on 01 September 2014
Morphosys is a leading biotechnology developing therapeutic antibodies for a range of different indications. Read the full story
MorphoSys and Celgene pharma deals for Oncology drug co-development and co-marketing in $818 million deal
Posted on 28 June 2013
MorphoSys, a big pharma, and Celgene, a big pharma and big biotech, announced pharma deals to jointly develop MOR202 globally and to co-promote MOR202 in Europe. Read the full story
